Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea

J. Mark Jackson, Douglas J. Lorenz, Leon H. Kircik

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Rosacea is one of the most commonly occurring dermatoses treated by dermatologists. There are multiple therapeutic options available for the treatment of papulopustular rosacea. Rosacea is an inflammatory condition, classically presenting with flushing and/ or blushing along with erythema, edema, telangiectasia, papules, pustules, and nodules of the face. Minocycline, a member of the tetracycline family, has demonstrated benefit in the treatment of inflammatory lesions in patients with rosacea. This manuscript highlights the use of a new sustained-release low-dose minocycline 45 mg tablet, with or without azelaic acid, for the treatment of papulopustular rosacea.

Original languageEnglish
Pages (from-to)292-298
Number of pages7
JournalJournal of Drugs in Dermatology
Volume12
Issue number3
StatePublished - Mar 2013

Fingerprint

Dive into the research topics of 'Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea'. Together they form a unique fingerprint.

Cite this